New Event! RYBREVANT FASPRO + LAZCLUZE for EGDR + Locally Advanced or Metastatic NSLC

Feb 18
0 min read

Recent Posts

See All

A New Treatment Approach for Cisplatin-Ineligible Patients with MICB*

New Event! Program on ZEPZELCA

ACS CAN’s 2026 Massachusetts Lobby Day on March 26th

NEW opportunity for oncology nurses in Massachusetts! Register to participate in ACS CAN’s 2026 Massachusetts Lobby Day on March 26 th . Please see details on the event below and you may register her

Comments